Stock ScreenerStock IdeasHigh Risk, High RewardHigh Risk, High Reward StocksSpeculative companies with the highest upside potential according to WallStreet analysts. Proceed with extreme caution!
Stock ScreenerStock IdeasHigh Risk, High Reward
Consensus: Strong Buy + 1 more
Analysts: >= 2
Upside/Downside: >= 500%
| Ticker | Company | Zen Rating | Sentiment | Market Cap | Shares | Institutional % | Insider % | Net Insider (L12M) | Net Insider (L3M) |
|---|---|---|---|---|---|---|---|---|---|
| KALA | KALA BIO INC | $5.46M | 8,209,725 | 3.32% | 96.68% | Net Selling | Net Selling | ||
| FBLG | FIBROBIOLOGICS INC | $17.70M | 51,456,077 | 10.48% | 12.05% | Net Buying | Net Buying | ||
| ACET | ADICET BIO INC | $80.94M | 9,578,474 | 75.47% | 24.53% | Net Buying | |||
| NRXP | NRX PHARMACEUTICALS INC | $68.84M | 28,097,627 | 7.36% | 92.64% | ||||
| SKYE | SKYE BIOSCIENCE INC | $35.58M | 32,057,461 | 2.73% | 97.27% | Net Selling | |||
| BTAI | BIOXCEL THERAPEUTICS INC | $44.61M | 21,869,491 | 1.18% | 98.82% | ||||
| TVRD | TVARDI THERAPEUTICS INC | $36.49M | 9,381,344 | 7.84% | 92.16% | Net Selling | |||
| ENLV | ENLIVEX THERAPEUTICS LTD | $19.97M | 24,292,833 | 3.72% | 59.15% | ||||
| OSTX | OS THERAPIES INC | $53.88M | 35,214,352 | 4.44% | 18.78% | Net Selling | |||
| SGMO | SANGAMO THERAPEUTICS INC | $154.79M | 336,494,489 | 18.60% | 9.54% | Net Selling | Net Selling | ||
| PSTV | PLUS THERAPEUTICS INC | $83.83M | 137,429,055 | 3.79% | 17.39% | Net Buying | Net Buying | ||
| FEMY | FEMASYS INC | $36.55M | 58,479,824 | 6.42% | 4.05% | Net Buying | |||
| RCKT | ROCKET PHARMACEUTICALS INC | $420.98M | 108,222,228 | 50.64% | 49.36% | Net Selling | Net Selling | ||
| CODX | CO-DIAGNOSTICS INC | $12.24M | 2,029,753 | 34.61% | 65.39% | Net Selling | Net Selling | ||
| LSTA | LISATA THERAPEUTICS INC | $18.61M | 8,820,733 | 0.84% | 99.16% | Net Selling | |||
| NAKA | KINDLY MD INC | $206.29M | 439,850,889 | 24.72% | 6.81% | Net Buying | |||
| VERU | VERU INC | $38.04M | 16,050,320 | 6.39% | 93.61% | Net Buying | |||
| SLN | SILENCE THERAPEUTICS PLC | $273.68M | 141,701,848 | 13.91% | 0.09% | ||||
| PDSB | PDS BIOTECHNOLOGY CORP | $46.68M | 48,980,307 | 11.47% | 24.13% | Net Buying | |||
| IMUX | IMMUNIC INC | $83.00M | 120,284,724 | 35.49% | 13.20% | Net Buying | |||
| PALI | PALISADE BIO INC | $300.99M | 149,003,210 | 0.08% | 5.55% | ||||
| RVPH | REVIVA PHARMACEUTICALS HOLDINGS INC | $39.81M | 115,058,619 | 8.25% | 9.28% | ||||
| SNTI | SENTI BIOSCIENCES INC | $30.23M | 26,290,838 | 18.58% | 81.42% | Net Buying | |||
| SXTP | 60 DEGREES PHARMACEUTICALS INC | $2.09M | 4,230,448 | 1.01% | 69.58% | Net Buying | Net Buying | ||
| ONCY | ONCOLYTICS BIOTECH INC | $99.59M | 103,635,734 | 2.72% | 1.90% | ||||
| AKTX | AKARI THERAPEUTICS PLC | $20.51M | 71,479,461,523 | 0.00% | 6.24% | Net Buying | Net Buying | ||
| KRRO | KORRO BIO INC | $79.95M | 9,417,295 | 25.66% | 74.34% | ||||
| PMN | PROMIS NEUROSCIENCES INC | $17.78M | 2,152,444 | 23.87% | 76.13% | Net Buying | |||
| MREO | MEREO BIOPHARMA GROUP PLC | $67.15M | 795,658,504 | 12.60% | 4.18% | ||||
| ATYR | ATYR PHARMA INC | $73.20M | 97,986,634 | 63.19% | 15.70% | Net Buying | Net Buying | ||
| IFRX | INFLARX NV | $81.30M | 67,747,130 | 27.40% | 0.00% | ||||
| SLE | SUPER LEAGUE ENTERPRISE INC | $6.18M | 10,075,954 | 0.22% | 40.75% | Net Selling | Net Selling | ||
| ZSPC | ZSPACE INC | $14.58M | 29,050,067 | 1.28% | 98.72% | Net Selling | Net Selling | ||
| CTSO | CYTOSORBENTS CORP | $42.71M | 62,804,305 | 26.01% | 45.21% | Net Buying | Net Buying | ||
| MSAI | MULTISENSOR AI HOLDINGS INC | $18.34M | 52,537,883 | 28.70% | 66.36% | Net Selling | |||
| CLGN | COLLPLANT BIOTECHNOLOGIES LTD | $16.72M | 11,454,512 | 13.23% | 0.00% | ||||
| VNRX | VOLITIONRX LTD | $35.12M | 122,801,572 | 21.27% | 31.03% | Net Buying | Net Buying | ||
| RANI | RANI THERAPEUTICS HOLDINGS INC | $168.90M | 121,511,580 | 3.32% | 33.62% | Net Selling | Net Selling | ||
| CING | CINGULATE INC | $33.58M | 6,757,070 | 3.76% | 96.24% | ||||
| HOWL | WEREWOLF THERAPEUTICS INC | $31.11M | 48,540,200 | 32.77% | 67.23% | Net Selling | Net Selling | ||
| HUMA | HUMACYTE INC | $224.73M | 187,271,321 | 24.49% | 16.42% | Net Selling | |||
| MYO | MYOMO INC | $40.36M | 38,435,524 | 35.34% | 11.08% | Net Buying | Net Buying | ||
| CABA | CABALETTA BIO INC | $206.01M | 96,265,204 | 71.90% | 4.39% | ||||
| HELP | CYBIN INC | $167.68M | 23,033,127 | 40.05% | 0.00% | ||||
| TNYA | TENAYA THERAPEUTICS INC | $133.20M | 166,505,885 | 20.74% | 22.99% | Net Buying | Net Selling | ||
| IBRX | IMMUNITYBIO INC | $2.17B | 984,965,179 | 14.52% | 7.77% | Net Selling | Net Selling | ||
| BMEA | BIOMEA FUSION INC | $94.04M | 70,703,639 | 35.45% | 24.59% | Net Buying | Net Buying |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.